{
   "title": "Novartis ' spending on research and development by segment 2017 to 2019",
   "labels": [
      "Company",
      "2017",
      "2018",
      "2019"
   ],
   "columnType": "multi",
   "graphType": "bar",
   "summaryType": "nlp",
   "summary": "This statistic shows the distribution of the remote patient monitoring market in north America in 2008 and 2015 with a forecast for 2022 , by country , in million u.s. dollars . In 2015 , the remote patient monitoring market in the u.s. was valued at around 175 million dollars and was expected to grow to almost 536 million dollars by the year 2022 .\n",
   "trends": {},
   "data": [
      {
         "Company": "Innovative Medicines",
         "2017": "7.62",
         "2018": "7.68",
         "2019": "8.15"
      },
      {
         "Company": "Sandoz",
         "2017": "0.77",
         "2018": "0.81",
         "2019": "1.25"
      },
      {
         "Company": "Alcon",
         "2017": "0.58",
         "2018": "0.59",
         "2019": "0"
      }
   ],
   "gold": "This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2019 , by business segment . In 2016 and 2017 , in both years , the company spent around 7.6 billion U.S. dollars for research and development in the Innovative Medicines division .\n"
}